Loading...
| A03972 | Pages: NA | Dec 2021 | 4621 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Latex Medical Gloves Market
Request Now !Latex is a natural material extracted from flowering plants. It can also be artificially manufactured by polymerizing monomer such as styrene, which is emulsified by surfactants. It is utilized to manufacture latex gloves for surgical and physical examination purposes. Latex gloves are widely used in healthcare practices and it is a popular choice among medical professionals. Latex gloves are biodegradable and provide high level of touch sensitivity and high elasticity. They also provide high dexterity and can work effectively to contain situations involving high infections.
Increase in awareness in healthcare providers and patients regarding healthy and safety measures and to inhibit infections through clinical or physical examinations drive the market. Moreover, rise in number of surgeries and infections is expected to boost the growth of this market. However, slight increase in latex-related allergies impede the market growth.
The global latex medical gloves market is segmented based on type, form, end user, and geography. By type, it is bifurcated into examination gloves & surgical gloves. Based on form, it is bifurcated into powdered form gloves and powder-free form gloves. Based on end user, the market is divided into hospital, clinic, ambulatory surgery center, diagnostic imaging center, and rehabilitation center. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. These regions are further analyzed across the globe at country level to determine the market size and forecast for each segment and sub-segment.
Comprehensive competitive analysis and profiles of major market players such as Thermo Fisher Scientific, Promega Corporation, Primerdesign, Bioneer corp, General Biosystems, BioFire Defense, MO BIO Laboratories, Bio-Rad Laboratories, Akonni Biosystems, and QIAGEN Inc. are provided in this report.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL LATEX MEDICAL GLOVES MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. EXAMINATION GLOVES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. SURGICAL GLOVES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 GLOBAL LATEX MEDICAL GLOVES MARKET, BY FORM
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. POWDERED FORM GLOVES
5.2.1. Market size and forecast
5.3. POWDER-FREE FORM GLOVES
5.3.1. Market size and forecast
CHAPTER 6 GLOBAL LATEX MEDICAL GLOVES MARKET, BY FORM
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITAL USE
6.2.1. Market size and forecast
6.3. CLINIC USE
6.3.1. Market size and forecast
6.4. AMBULATORY SURGERY CENTRE USE
6.4.1. Market size and forecast
6.5. DIAGNOSTIC IMAGING CENTRE USE
6.5.1. Market size and forecast
6.6. REHABILITATION CENTRE USE
6.6.1. Market size and forecast
CHAPTER 7 LATEX MEDICAL GLOVES MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. South Africa market size and forecast
7.5.3.5. Rest of LAMEA market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1. THERMO FISHER SCIENTIFIC INC
8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments
8.2. PROMEGA CORPORATION
8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments
8.3. PRIMERDESIGN
8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments
8.4. BIONEER CORP
8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments
8.5. GENERAL BIOSYSTEMS
8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments
8.6. BIOFIRE DEFENSE
8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments
8.7. MO BIO LABORATORIES
8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments
8.8. BIO-RAD LABORATORIES
8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments
8.9. AKONNI BIOSYSTEMS
8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments
8.10. QIAGEN INC
8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
